Strong Year-Over-Year Growth
Annual recurring revenue increased by 43% year-over-year. Total revenue for the quarter rose by 32%, and gross profit was up by 34%.
Record New Customer Wins
The company achieved record new customer wins, including strategic accounts in generic pharmaceuticals, clinical diagnostics, and medical devices.
Product Innovation
Released Kneat Gx version 9.5, enhancing data management capabilities and enabling risk-based validation processes.
Leadership Additions
Strategic hires were made throughout the company, including new leadership in product and engineering.
Positive Pipeline Outlook
The company reported a strong and diverse pipeline, including new opportunities in med tech and other non-core areas.